NASDAQ: KYTX
Kyverna Therapeutics Inc Stock Ownership - Who owns Kyverna Therapeutics?

Insider buying vs selling

Have Kyverna Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christi ShawExecutive Chairperson2026-05-274,194$8.59
$36.03kSell
Beth C. SeidenbergDirector2025-12-18133,333$7.50
$1,000.00kBuy
Westlake Biopartners Opportunity Fund I LP10% Owner2025-12-18133,333$7.50
$1,000.00kBuy
Karen Marie WalkerChief Technology Officer2025-12-1523,998$4.83
$115.91kBuy
Karen Marie WalkerChief Technology Officer2025-12-1523,998$12.20
$292.78kSell

1 of 1

KYTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYTX insiders and whales buy or sell their stock.

KYTX Shareholders

What type of owners hold Kyverna Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vida Ventures LLC7.72%4,777,060$34.06MInsider
Fred E. Cohen7.35%4,545,651$32.41MInsider
Gilead Sciences Inc6.67%4,126,119$29.42MInsider
Westlake Biopartners Opportunity Fund I LP6.13%3,787,940$27.01MInsider
Northpond Ventures III GP LLC5.26%3,255,426$23.21MInsider
Bain Capital Life Sciences Investors LLC5.12%3,163,868$22.56MInsider
Beth C. Seidenberg1.44%891,044$6.35MInsider
Westlake Biopartners Fund I LP1.19%735,984$5.25MInsider
Dominique Christian Borie0.73%449,210$3.20MInsider
Peter Maag0.66%407,541$2.91MInsider

1 of 3

KYTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYTX0.06%42.88%Net Buying
PRTA0.09%83.15%Net BuyingNet Selling
RLMD0.09%3.69%Net BuyingNet Buying
TTRX0.00%58.04%Net Buying
CABA0.09%2.57%Net Buying

Kyverna Therapeutics Stock Ownership FAQ

Who owns Kyverna Therapeutics?

Kyverna Therapeutics (NASDAQ: KYTX) is owned by 0.06% institutional shareholders, 42.88% Kyverna Therapeutics insiders, and 57.06% retail investors. Vida Ventures LLC is the largest individual Kyverna Therapeutics shareholder, owning 4.78M shares representing 7.72% of the company. Vida Ventures LLC's Kyverna Therapeutics shares are currently valued at $34.06M.

If you're new to stock investing, here's how to buy Kyverna Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.